LLY

1,030.06

+0.68%↑

JNJ

243.75

+1.91%↑

ABBV

224.33

+1.19%↑

NVS

160.78

+0.8%↑

MRK

120.94

+2.06%↑

LLY

1,030.06

+0.68%↑

JNJ

243.75

+1.91%↑

ABBV

224.33

+1.19%↑

NVS

160.78

+0.8%↑

MRK

120.94

+2.06%↑

LLY

1,030.06

+0.68%↑

JNJ

243.75

+1.91%↑

ABBV

224.33

+1.19%↑

NVS

160.78

+0.8%↑

MRK

120.94

+2.06%↑

LLY

1,030.06

+0.68%↑

JNJ

243.75

+1.91%↑

ABBV

224.33

+1.19%↑

NVS

160.78

+0.8%↑

MRK

120.94

+2.06%↑

LLY

1,030.06

+0.68%↑

JNJ

243.75

+1.91%↑

ABBV

224.33

+1.19%↑

NVS

160.78

+0.8%↑

MRK

120.94

+2.06%↑

Search

Integra LifeSciences Holdings Corp

Ouvert

SecteurSoins de santé

10.99 3

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.61

Max

11.19

Chiffres clés

By Trading Economics

Revenu

479M

-5.4M

Ventes

-14M

402M

Marge bénéficiaire

-1.344

Employés

4,396

EBITDA

526M

54M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+18.94% upside

Dividendes

By Dow Jones

Prochains Résultats

26 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-404M

852M

Ouverture précédente

7.99

Clôture précédente

10.99

Sentiment de l'Actualité

By Acuity

78%

22%

329 / 352 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

11 févr. 2026, 23:47 UTC

Actions en Tendance

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11 févr. 2026, 22:59 UTC

Résultats
Acquisitions, Fusions, Rachats

Grab Holdings to Buy U.S.-Based Stash Financial

11 févr. 2026, 23:54 UTC

Résultats

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11 févr. 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

11 févr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11 févr. 2026, 23:49 UTC

Résultats

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11 févr. 2026, 23:45 UTC

Résultats

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11 févr. 2026, 23:42 UTC

Résultats

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11 févr. 2026, 23:41 UTC

Résultats

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11 févr. 2026, 23:40 UTC

Résultats

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11 févr. 2026, 23:35 UTC

Market Talk

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11 févr. 2026, 23:18 UTC

Market Talk

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11 févr. 2026, 23:14 UTC

Market Talk

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11 févr. 2026, 22:59 UTC

Résultats

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11 févr. 2026, 22:59 UTC

Résultats

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11 févr. 2026, 22:59 UTC

Résultats

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11 févr. 2026, 22:58 UTC

Résultats

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11 févr. 2026, 22:57 UTC

Résultats

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11 févr. 2026, 22:54 UTC

Résultats

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11 févr. 2026, 22:53 UTC

Résultats

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11 févr. 2026, 22:47 UTC

Résultats

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 févr. 2026, 22:47 UTC

Résultats

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 févr. 2026, 22:23 UTC

Résultats

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11 févr. 2026, 22:22 UTC

Résultats

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11 févr. 2026, 22:22 UTC

Résultats

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11 févr. 2026, 22:19 UTC

Résultats

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11 févr. 2026, 22:18 UTC

Résultats

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11 févr. 2026, 22:18 UTC

Résultats

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11 févr. 2026, 22:18 UTC

Résultats

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11 févr. 2026, 22:16 UTC

Résultats

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

18.94% hausse

Prévisions sur 12 Mois

Moyen 13 USD  18.94%

Haut 13 USD

Bas 13 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

3 ratings

0

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

329 / 352Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat